Xywav
Ended Awarded Last action
- Contract number
- 36C26025F0161
- Awardee
-
Jazz Pharmaceuticals, Inc. UEI H9AXCNRA5NE6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $240,735
Award facts
- Contract value 100% obligated
- $240,735.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Normandy, MO 63121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $4,697 | |
| Original award | $236,038 |
About this award
This delivery order award to Jazz Pharmaceuticals, Inc. represents a $240,735.13 firm fixed price contract issued by the Department of Veterans Affairs' Veterans Integrated Service Network 20 for the supply of Xywav (calcium/magnesium/potassium/sodium oxybate), a specialty pharmaceutical treatment for narcolepsy and sleep disorders. The contract was awarded on March 9, 2025, with a completion date of March 9, 2026, and is being performed in Normandy, Missouri. This award is issued as a delivery order under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and Jazz Pharmaceuticals' existing Blanket Purchase Agreement with the VA's National Acquisition Center, valued at approximately $161.2 million and expiring August 15, 2026.
No set-aside designation was applied to this award, reflecting competitive, unrestricted procurement. Jazz Pharmaceuticals, a global biopharmaceutical company headquartered in Palo Alto, California, serves as the prime contractor with no identified subcontracting arrangements. The company has established itself as a critical supplier of sleep disorder medications to the VA healthcare system, with sustained delivery order activity spanning multiple Veterans Integrated Service Networks since 2021. This award supports the VA's mission to provide specialized healthcare services to veterans by ensuring reliable access to essential pharmaceutical products for treating neurological and sleep-related conditions across the veteran population.
Quick answers
Who was awarded contract 36C26025F0161?
36C26025F0161 was awarded to Jazz Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 9, 2025.
How much is contract 36C26025F0161 worth?
The government has obligated $240,735 on 36C26025F0161.
Is contract 36C26025F0161 an order under another contract?
Yes. 36C26025F0161 is a delivery order under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0161 competed?
The extent of competition for 36C26025F0161 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award